Erasca (ERAS) Cash from Operations (2020 - 2026)
Erasca (ERAS) posted Cash from Operations of 27383000.0 for Q1 2026, down 26.13% on a QoQ basis from 21711000.0 in Q4 2025, and up 13.22% year-over-year from 24185365.83 in Q1 2025.
Erasca (ERAS) Cash from Operations (2020 - 2026) Analysis & Trends
Erasca's Cash from Operations history runs 7 years deep, the most recent figure standing at 27383000.0 for Q1 2026.
- Quarterly Cash from Operations rose 13.22% year-over-year to 27383000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 91283000.0 (up 15.26% YoY) and the FY2025 annual result came in at 95455000.0, up 12.76% from the prior year.
- Cash from Operations was 27383000.0 for Q1 2026 at Erasca, down from 21711000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 20531000.0 in Q2 2025 and bottomed at 33251000.0 in Q1 2024.
- A 5-year average of 25690352.94 and a median of 25806000.0 in 2022 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations slumped 64.73% — and 2025, when it advanced 29.65%.
- Erasca's Cash from Operations stood at 26372000.0 in 2022, then rose by 6.01% to 24788000.0 in 2023, then rose by 0.9% to 24564000.0 in 2024, then gained by 11.61% to 21711000.0 in 2025, then dropped by 26.13% to 27383000.0 in 2026.
- Business Quant data shows ERAS's Cash from Operations at 27383000.0 in Q1 2026, 21711000.0 in Q4 2025, and 21658000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | -27.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.38 Mn |
| Mar 31, 2026 | -27.38 Mn |
| Dec 31, 2025 | -21.71 Mn |
| Dec 31, 2025 | -21.71 Mn |
| Sep 30, 2025 | -21.66 Mn |
| Sep 30, 2025 | -21.66 Mn |
| Jun 30, 2025 | -20.53 Mn |
| Jun 30, 2025 | -20.53 Mn |
| Mar 31, 2025 | -31.56 Mn |
| Mar 31, 2025 | -31.56 Mn |
| Dec 31, 2024 | -24.56 Mn |
| Dec 31, 2024 | -24.56 Mn |
| Sep 30, 2024 | -22.42 Mn |
| Sep 30, 2024 | -22.42 Mn |
| Jun 30, 2024 | -29.18 Mn |
| Jun 30, 2024 | -29.18 Mn |
| Mar 31, 2024 | -33.25 Mn |
| Mar 31, 2024 | -33.25 Mn |
| Dec 31, 2023 | -24.79 Mn |
| Dec 31, 2023 | -24.79 Mn |